Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DFB62M
|
|||
| Drug Name |
Hepzato
|
|||
| Indication | Uveal Melanoma [ICD-11: 2D0Y] | Phase 3 | [1] | |
| Company |
Delcath Systems
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05022901) An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.